COVID-19 Cardiac Manifestations and Scent Perception Genes in Hearts of SARS-Cov-2 Infected Patients: A Meta-Analysis of Gene Expression Data
DOI:
https://doi.org/10.31661/gmj.v10i.2250Keywords:
COVID-19, SARS-Cov-2, Cardiac, Myocardial Infarction, HeartAbstract
Background: COVID-19 induced cardiac events are reported by many papers, while psychophysiology of association of the COVID-19 and cardiac attacks are not fully understood yet. Materials and Methods: Here, we compared gene expression levels of heart autopsies of SARS-Cov-2 infected patients with the cardiac organoid model of human myocardial infarction and controlled healthy cardiac organoids to identify differentially expressed genes (DEGs). Gene Ontology (GO) biological processes were enriched in DEGs. Results: Results showed that smell perception genes were down-regulated in SARS-COV2 compared to myocardial infarction samples; while showing upregulated genes related to the immune system process in contrast to control healthy heart organoids. Our results agree with theories of immune system reactions in COVID-19 infected patients’ hearts, while our analysis indicates different patterns of heart gene expression from myocardial infarction models. Conclusion: our study suggests that there may be other pathways involved in MI appearance in COVID-19 patients rather than classic is known atherosclerotic and inflammatory pathways. [GMJ.2021;10:e2250]
References
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352-71. https://doi.org/10.1016/j.jacc.2020.03.031PMid:32201335 PMCid:PMC7198856 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3 Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. https://doi.org/10.1001/jamacardio.2020.1017PMid:32219356 PMCid:PMC7101506 Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345-53. https://doi.org/10.1056/NEJMoa1702090PMid:29365305 Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https://doi.org/10.1186/s13059-014-0550-8PMid:25516281 PMCid:PMC4302049 Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020;395(10229):1038. https://doi.org/10.1016/S0140-6736(20)30566-3 Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585PMid:32031570 PMCid:PMC7042881 Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?. Heart. 2020;106:1127-31. https://doi.org/10.1136/heartjnl-2020-317186PMid:32499236 Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARSâ€coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618-25. https://doi.org/10.1111/j.1365-2362.2009.02153.xPMid:19453650 PMCid:PMC7163766 Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, et al. Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection. Nat Commun. 2020;11(1):6319. https://doi.org/10.1038/s41467-020-20139-7PMid:33298930 PMCid:PMC7725958 Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457-60. https://doi.org/10.1007/s11427-020-1637-5PMid:32009228 PMCid:PMC7089049 Drutel G, Arrang JM, Diaz J, Wisnewsky C, Schwartz K, Schwartz JC. Cloning of OL1, a putative olfactory receptor and its expression in the developing rat heart. Recept Channels. 1995;3(1):33-40. Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. 2021;278(2):307-12. https://doi.org/10.1007/s00405-020-06120-6PMid:32556781 PMCid:PMC7297932 Parsa S, Mogharab V, Ebrahimi M, Ahmadi SR, Shahi B, Mehramiz NJ, et al. COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study. Int J Biol Macromol. 2021;177:204-10. https://doi.org/10.1016/j.ijbiomac.2021.02.070PMid:33582215 PMCid:PMC8043766 Islam AB, Khan MA. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy. Sci Rep. 2020;10(1):1-6. https://doi.org/10.1038/s41598-020-76404-8PMid:33173052 PMCid:PMC7656460 Gutierrez JA, Parry AJ, McMullan DM, Fineman JR. Increased pulmonary blood flow decreases surfactant protein a in a lamb model of congenital heart disease. Pediatr Res. 1999;45(7):352. https://doi.org/10.1203/00006450-199904020-02090 De Pasquale CG. Surfactant protein-B in chronic heart failure: an insight to the alveolocapillary barrier. Rev Esp Cardiol. 2009;62(2):117-9. https://doi.org/10.1016/S0300-8932(09)70152-6 Gargiulo P, Banfi C, Ghilardi S, Magri D, Giovannardi M, Bonomi A, et al. Surfactant-derived proteins as markers of alveolar membrane damage in heart failure. PLoS One. 2014;9(12):e115030. https://doi.org/10.1371/journal.pone.0115030PMid:25514679 PMCid:PMC4267772 Gadwal A, Roy D, Khokhar M, Modi A, Sharma P, Purohit P. CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19. Indian J Clin Biochem. 2021;36(4):1-9. https://doi.org/10.1007/s12291-021-00977-yPMid:33879980 PMCid:PMC8050156 Daamen AR, Bachali P, Owen KA, Kingsmore KM, Hubbard EL, Labonte AC, et al. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep. 2021;11(1):7052. https://doi.org/10.1038/s41598-021-86002-xPMid:33782412 PMCid:PMC8007747 Shaath H, Vishnubalaji R, Elkord E, Alajez NM. Single-cell transcriptome analysis highlights a role for neutrophils and inflammatory macrophages in the pathogenesis of severe COVID-19. Cells. 2020;9(11):2374. https://doi.org/10.3390/cells9112374PMid:33138195 PMCid:PMC7693119
